Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Net Margin (2019 - 2025)

Historic Net Margin for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 5.01%.

  • Volitionrx's Net Margin rose 12218100.0% to 5.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 768.77%, marking a year-over-year increase of 15544600.0%. This contributed to the annual value of 2186.27% for FY2024, which is 23692600.0% up from last year.
  • Latest data reveals that Volitionrx reported Net Margin of 5.01% as of Q3 2025, which was up 12218100.0% from 7.37% recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Net Margin ranged from a high of 513.26% in Q4 2021 and a low of 5860.53% during Q1 2023
  • Over the past 5 years, Volitionrx's median Net Margin value was 5.01% (recorded in 2025), while the average stood at 1605.89%.
  • In the last 5 years, Volitionrx's Net Margin soared by 2000000000bps in 2021 and then crashed by -59340600bps in 2023.
  • Volitionrx's Net Margin (Quarter) stood at 513.26% in 2021, then plummeted by -85bps to 78.6% in 2022, then crashed by -4636bps to 3565.25% in 2023, then rose by 15bps to 3022.78% in 2024, then skyrocketed by 100bps to 5.01% in 2025.
  • Its Net Margin stands at 5.01% for Q3 2025, versus 7.37% for Q2 2025 and 2241.03% for Q1 2025.